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Introduction
High-throughput gene regulation studies have focused primarily 
on quantifying gene expression and calculating differential 
gene expression (DGE) between samples in different groups, 
conditions, treatments, or time-points. However, in higher 
eukaryotes, alternative splicing of multi-exon genes and/or 
alternative transcript start and end sites leads to multiple tran-
script isoforms originating from each gene. Since transcripts 
represent the executive form of genetic information, analysis of 
differential transcript expression (DTE) is preferable to DGE. 
Unfortunately, isoform-level transcriptome analysis is more 
complex and expensive since, in order to achieve similar 
statistical power in a DTE study, higher sequencing depth is 
required to compensate for the expression of each gene being 
split among its component isoforms. In addition, isoforms 
of a gene share high sequence similarity and this compli-
cates the attribution of reads among them. Despite these chal-
lenges, several studies have shown that isoforms have distinct 
functions1–3 and that shifts in individual isoform expression 
represent a real level of gene regulation4–7, suggesting there is 
little justification for choosing DGE over DTE in the study of 
complex transcriptomes.
It is possible to find significant DTE among the isoforms of a gene, 
even when the gene shows no significant DGE. This introduces the 
concept of differential transcript usage (DTU), where the abun-
dances of individual isoforms of a gene can change relative to one 
another, with the most pronounced examples resulting in a change 
of the dominant isoform (isoform switching). The definitions of 
DGE, DTE and DTU are illustrated in Figure 1.
To quantify the isoforms and assess changes in their abundance, 
most existing tools for DTE and DTU analysis (e.g. Cufflinks8, 
DEXSeq9, LeafCutter10) rely on reads that either span splice-
junctions or align to unique exons. However, with the newest 
generation of transcript quantification tools (Kallisto11,12, Sailfish13, 
Salmon14), reads are aligned to neither the transcriptome nor 
the genome. Instead, these tools combine a pseudo-mapping of 
the k-mers present within each read to the k-mer distributions 
from the transcriptome annotation with an expectation maximi-
zation algorithm, to infer the expression of each transcript model 
directly. Such alignment-free methods are much faster than 
the traditional alignment-based methods (RSEM15, TopHat216, 
STAR17) or assembly-based methods (Cufflinks8, Trinity18), making 
it feasible to repeat the process many times on iterative subsets of 
the read data and, thus, quantify the technical variance in the tran-
script abundance estimates. However, the lack of alignments pre-
vents these new methods from being compatible with differential 
expression methods such as Cufflinks, DEXSeq and Leafcutter. 
Instead, Sleuth19 is a tool that handles DTE analysis from align-
ment-free transcript quantifications. DTU analysis is currently 
less straight-forward. SwitchSeq20 focuses on a particular subset of 
DTU analysis from alignment-free data, namely isoform switch-
ing, whereas iso-kTSP6 identifies both DTU and isoform switching, 
but focuses on the highest-ranking pair of change-exhibiting 
isoforms per gene. SUPPA21,22, on the other hand, primarily 
Figure 1. Illustrative definitions of the three types of differential expression analysis (DGE, DTE and DTU). The expression of two 
genes (Gene A and Gene B), with 3 and 2 isoforms respectively, is compared across two conditions (Condition 1 and Condition 2). The 
horizontal width of each coloured box represents the abundance of the relevant gene or transcript. A negative differential expression result 
(red cross-mark) for a given entity in any one of the three analysis types does not exclude that same entity from having a positive result 
(green tick-mark) in one of the other two analysis types. The relative isoform abundances in [iii] are scaled to the absolute isoform 
abundances in [ii], which in turn are scaled to the gene expressions in [i]. Gene A is differentially expressed, but only two of its three isoforms 
are differentially expressed (A.2 and A.3). Proportionally, Gene A’s primary isoform (A.3) remains the same, but the ratios of the two less 
abundant isoforms change. Gene B is not differentially expressed, but both its isoforms are differentially expressed, and demonstrate an 
example of isoform switching. DGE: Differential gene expression, DTE: Differential transcript expression, DTU: Differential transcript usage.
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identifies differential splicing events at the junction level, with 
recent developmental versions having added isoform-level 
capability. Finally, DRIM-Seq23 identifies DTU directly from 
quantification data, but defines the effect size as a fold change 
which may not be the most appropriate way to compare 
proportions.
In this paper, we present RATs (Relative Abundance of 
Transcripts), an R package for identifying DTU directly from 
isoform quantifications. It is designed to use alignment-free 
abundance data and is the only tool that exploits bootstrap-
ping to assess the robustness of the DTU calls. RATs provides 
raw, summary and graphical results, allowing for ease of use 
as well as for advanced custom queries, and the R language 
is the environment of choice for many widely-used DGE and 
DTE tools, allowing for easy integration of RATs in existing 
workflows. We assess the accuracy of RATs in comparison to 
SUPPA2 and DRIM-Seq and find RATs to perform at as well as 
or better than its competitors. Finally, we demonstrate that the 
results of both RNA-seq based and qRT-PCR based analyses are 




RATs identifies DTU independently at both the gene and 
transcript levels using an efficient implementation of the G-test 
of independence24, without continuity corrections. The criteria 
RATs uses to identify DTU are described in detail below.
Pre-filtering
Prior to statistical testing by either method, RATs first filters the 
input isoform abundance data to reduce both the number of low 
quality calls and the number of tests carried out. Specifically: 
(i) isoform ratio changes can only be defined for genes that 
are expressed in both conditions, with at least two isoforms 
detected, and (ii) transcript abundances must exceed an optional 
minimum abundance threshold. Transcripts with abundances 
below the threshold are considered as not detected.
Statistical significance
Significant changes in relative transcript abundance are detected 
using two separate approaches: one at the gene level and the 
other at the transcript level. At the gene level, RATs compares 
the set of each gene’s isoform abundances between the two 
conditions to identify if the abundance ratios have changed. At the 
transcript level, RATs compares the abundance of each individual 
transcript against the pooled abundance of its sibling isoforms 
to identify changes in the proportion of the gene’s expression 
attributable to that specific transcript. Both methods include 
the Benjamini-Hochberg false discovery rate correction for 
multiple testing25. These tests are performed on the summed 
abundance of each isoform across the replicates.
Effect size
Transcripts whose absolute difference in isoform proportion 
is below a set threshold are rejected, even if the difference is 
statistically significant.
Reproducibility
RATs provides the option to use the bootstrapped abundance 
estimates obtainable from alignment-free quantification tools to 
apply a reproducibility constraint on the DTU calls, by randomly 
selecting individual quantification iterations from each replicate 
and measuring the fraction of these iterations that result in a 
positive DTU classification. Typically, each sample is represented 
by the mean abundance of each transcript, calculated across 
the quantification iterations. However, this loses the variance 
information of the quantification. By referring back to the quan-
tification iterations, RATs highlights cases where the quantifi-
cation was unreliable due to high variability and therefore the 
DTU result should also be considered unreliable. Similarly, 
RATs optionally also measures the reproducibility of the DTU 
results relative to the inter-replicate variation by iteratively 
sub-setting the samples pool.
Implementation
RATs is implemented in R26 and has been freely distributed 
through Github as an R source package since August 2016. 
RATs accepts as input either a set of R tables with abundances 
(with or without bootstrap information), or a set of Salmon14 or 
Kallisto11 output files. An annotation table mapping the corre-
spondence between transcript and gene identifiers is also required, 
either provided directly or inferred from a GTF file. Results are 
returned in the form of R data.table objects27. Along with the 
DTU calls per transcript and gene, the tables record the full 
provenance of the results. Convenience functions are provided 
for summary tallies of DTU and isoform-switching results, 
for ID retrieval, and for visualization of the results via ggplot2 
(v2.2.1)28. Details on these are available through the user 
manual of the package. Once created, all plots produced by 
RATs remain customisable via standard ggplot2 operations.
Performance
The performance was assessed in two ways. Firstly, the false 
positives (FP) performance of RATs (v0.6.2) for detection of 
DTU between two groups relative to the level of experimental 
replication was measured on groups generated by random 
selection without replacement from a pool of 16 high-quality 
wild-type Colombia-0 Arabidopsis thaliana replicates29 1. This 
was iterated 100 times for each replication level in the range 
3 ≤ n ≤ 8. As the two groups are drawn from the same 
condition, any positive DTU calls must be considered to be false 
positives. For each iteration, we recorded the fraction of genes 
and transcripts that were reported as DTU, relative to the total 
number of genes or transcripts tested in that iteration. The 
commands and scripts used are from the RATs Github repository.
Secondly, two simulated datasets30 were used to benchmark 
the sensitivity (s, the fraction of the 1000 DTU events actually 
detected), false discovery rate (FDR, the fraction of reported 
DTU events that is not part of the 1000 “real” events) and 
Matthews correlation coefficient (MCC) of RATs, SUPPA2 and 
DRIM-Seq. The datasets were made of simulated RNA-seq 
1https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5446/
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reads based on the transcriptome annotation and to match 
realistic RNA-seq transcript expression values. To create the sec-
ond condition, the abundance values of the two most abundant 
transcript isoforms originating from a gene locus were swapped 
for 1000 well-expressed coding gene loci. The transcriptome 
annotation used for both Human and fly comprised only 
annotated protein coding genes (13937 in the Drosophila, 
20410 in the human) leaving a number of other classifications 
of gene unaccounted for (1745 in the Drosophila, 41483 in the 
human). These genes constitute a convenient negative set for 
simulation and should have no expression, save for any reads 
misallocated to them by the quantification tools. The simulated 
datasets were obtained from ArrayExpress2 and quantified with 
both Kallisto (v0.44;11 and Salmon (v0.9.1;14 using the respec-
tive complete annotations that match the simulation of the 
datasets (Ensembl v70 for the Drosophila and Ensembl v71 for 
the human;30). The sensitivity, FDR and MCC were measured 
for a range of comparable parameters between RATs (v0.6.4), 
SUPPA2 (v2.3) and DRIM-Seq (v1.6, Bioconductor v3.6, R v3.4). 
No transcript abundance pre-filter was imposed on any of the 
three DTU tools, and the significance level was set to 0.05 
for all runs. For RATs and SUPPA2, three thresholds for the 
effect size (difference in proportion) were tested; the RATs’ 
current default of 0.2, and more permissive values 0.1 & 0.05. 
For DRIM-Seq, threshold values of the likelihood ratio were 
explored from 0-30. Finally, RATs reproducibility thresholds 
were explored in the range of 0.8-0.95 for the quantification 
reproducibility and 0.55-0.85 for the inter-replicate reproduc-
ibility. The tool performance was measured using annota-
tions comprised of all annotated genes and only protein coding 
genes.
Comparison on a real 2-condition dataset
To test the ability of RATs to identify known instances of 
DTU, we compared it against validated instances of DTU from 
publicly available RNA-seq data. We took read data from Deng 
et al. (2013, 31), who identified non-DGE changes in the isoform 
levels of genes between three human patients with idiopathic 
pulmonary fibrosis (IPF) and three lung cancer patients used as 
controls. The dataset contains 25 million 54-base long single- 
end Illumina reads per lung tissue sample. As in the original 
at study, we used Ensembl v6032 as the source of the reference 
human genome and its annotation, in which each of the three 
discussed genes features two isoforms. Unlike the original 
study, we used Salmon (v0.7.1, with sequence bias correction 
enabled, 100 bootstrap iterations and default values for the 
remaining parameters, using k=21 for the index) to quantify the 
isoform abundances. DTU was identified by RATs v0.6.2. For 
comparison, we repeated the quantification and DTU analysis of 
the data with the same tool versions and parameters, but using 
the annotation and assembly from Ensembl v87, the current 
version at the time of this study.
We also submitted the quantification data to SUPPA2, in its 
psiPerIsoform mode, and to DRIM-Seq. For a fair comparison, 
we tried to minimize variability in the parameters and data type 
used by the three tools. As SUPPA2 offered no abundance 
pre-filtering, RATs and DRIM-Seq were run with abundance 
threshold values of 0. The p-value cut-off was set at 0.05 for all 
three tools, using the corrected p-values where available. For 
the difference in isoform proportion (SUPPA2 and RATs) the 
threshold was set at 0.20. No threshold was set for the 
fold-changes in DRIM-Seq. SUPPA2 required and was provided 
with TPM abundances. For consistency in the use of abundances 
normalised for transcript length, RATs and DRIM-Seq were 
also provided with TPM, but the values were scaled up to the 
average library size of 25M reads, as their testing methods 
expect counts and would be under-powered if used directly with 
TPMs. Again, the commands and scripts used are available from 
the RATs Github repository.
Results
False positives performance
Both the gene-level and transcript-level approaches to identifying 
DTU implemented in RATs achieved a median FP fraction 
<0.05 on our A. thaliana dataset, even with only three replicates 
per condition (Figure 2A). Higher replication results in both 
a reduction in the number of false positives and restricts the 
false positives to smaller effect sizes (Figure 2B). The gene-
level and transcript-level approaches, however, have different 
strengths and weaknesses. Simultaneously utilizing the expres-
sion information across all the isoforms in a gene makes the 
gene-level test sensitive to smaller changes in relative expres-
sion, compared to testing transcripts individually, but it also 
makes the gene-level test more prone to false positives. Figure 2 
shows that the gene-level test has a higher FP fraction than the 
transcript-level test, irrespective of replication level or effect 
size, although the two methods converge for highly replicated 
experiments or large effect sizes. Furthermore, the gene-level 
test only identifies the presence of a shift in the ratios of the 
isoforms belonging to the gene, without identifying which 
specific isoforms are affected. The transcript-level test, in con-
trast, directly identifies the specific isoforms whose proportions 
are changing and has fewer false positives than the gene-level 
test. However, considering each isoform independently requires 
a larger number of tests to be performed, thus resulting in a 
greater multiple testing penalty.
Comparative performance on simulated DTU
The sensitivity, FDR and MCC performance of RATs, SUPPA2 
and DRIM-Seq using Salmon transcript quantifications of 
annotated protein coding gene isoforms are summarised in 
Figure 3. Tested with the simulated Human dataset, the parame-
ter defaults for RATs (quantification reproducibility >95%, inter-
replicate reproducibility >85% & effect-size >0.2) result in a 
sensitivity of s = 0.55, MCC = 0.71 and FDR = 0.04, outper-
forming both other tools. With the same thresholds, SUPPA2 
has a higher sensitivity (s = 0.61) but poorer FDR perform-
ance (FDR = 0.33). Direct comparison with DRIM-Seq is 
complicated by different methods for measuring DTU effect-
sizes between the tools, however for a likelihood-ratio thresh-
old of 30, DRIM-Seq has similar FDR performance to RATs 
(FDR = 0.06), but worse sensitivity (s = 0.47). These differences 2https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3766/
Page 5 of 20
F1000Research 2019, 8:213 Last updated: 18 MAR 2019
Figure 2. False positives (FP) performance of RATs as a function of replication level. False positive fraction measured over 
100 permutation iterations of randomly selected (without replacement) replicates from a pool of 16 high-quality wild-type Colombia-0 
Arabidopsis thaliana replicates from Froussios et al. (2017,29). [A] FP fraction of each bootstrap iteration, for default values of all RATs 
parameters (v0.6.2), across a range of replication levels, separately for the gene-level test (red) and transcript level test (blue). [B] Mean FP 
fraction by replication level, as a function of the effect size threshold (effect size = difference between conditions of an isoform’s proportion). 
For a gene, the effect size is defined as the largest proportion difference observed among that gene’s isoforms. In every iteration, the FP 
fraction was calculated against the number of genes or transcripts that were eligible for testing each time (a number which remains very 
stable across iterations and replication levels – see Extended data 133).
Figure 3. Performance comparison between RATs, SUPPA2 and DRIM-Seq. The performance was assessed on the human [A] and 
Drosophila [B] simulated datasets from ArrayExpress E-MTAB-376630, over a range of threshold values for the effect size (RATs - Dprop, 
SUPPA2 - dPSI, DRIM-Seq likelihood ratio - lr) and confidence in the result (RATs quantification reproducibility – Qrep, RATs inter-replicate 
reproducibility - Rrep). The statistical significance cut-off was at 0.05 for all cases. The measures of performance are the sensitivity, false 
discovery rate (FDR) and Matthews correlation coefficient (MCC). The datasets were quantified using Salmon 0.9.2 and the metrics were 
calculated accounting only for the genes strictly listed in the “truth” sets. The results using Kallisto for the quantification are practically 
identical (see Extended data 233).
persist for the simulated drosophila dataset. DRIM-Seq consist-
ently shows the lowest sensitivity (≤0.65), while maintaining a 
FDR ≤0.2 in any of the tried parameter sets. SUPPA2 is the most 
sensitive of the three tools (0.6 ≤ s ≤ 0.9), but also has the highest 
FDR (0.35 ≤ FDR ≤ 0.65 in human, 0.10 ≤ FDR ≤ 0.25 in 
Drosophila). RATs can match the sensitivity of SUPPA2 while 
maintaining a lower FDR than SUPPA2 by relaxing its quan-
tification reproducibility (Qrep) and inter-replicate reproduc-
ibility (Rrep) thresholds. At the highest effect-size thresholds 
(DpropRATs = 0.2 and lrDRIM-Seq = 0.3) DRIM-Seq has a comparable 
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FDR to that of RATs. Surprisingly, the sensitivity, MCC and 
FDR of DRIM-Seq is not strongly sensitive to variations in the 
likelihood ratio effect-size threshold. Consequentially, RATs has 
worse FDR performance, but better sensitivity than DRIM-Seq 
at lower effect-size thresholds. Across all the simulated dataset 
and parameter combinations the gene-level test implemented in 
RATs shows higher sensitivity and higher FDR compared with 
the results from the transcript-level test. Extending the test to 
isoforms from the full set of annotated genes, rather than only 
those from protein coding genes, adds a considerable number of 
additional true negatives (Drosophila: 1745, human: 4148, see 
Section: Performance) resulting in a small increase of FDR 
and slight reduction of MCC for all tools in both datasets 
(Extended data 233). Similarly, using Kallisto isoform expres-
sion quantifications in place of the quantifications from Salmon 
does not strongly affect the results (Extended data 233). The 
performance results of RATs on these simulated datasets are 
in good agreement with those presented in Love et al. (2018,34), 
which also demonstrates that the performance of RATs is similar 
to, or exceeds, the performace of other DTU tools, including 
DRIM-seq, SUPPA2 or DEX-Seq.
Recapitulating published validated examples of DTU
After pre-filtering, Deng et al. (2013, 31) tested 3098 Ensembl 
v60 genes for DTU by quantifying their isoform propor-
tions with RAEM35 and using Pearsons Chi-squared test of 
independence with a FDR threshold of 5%. They identified 
248 genes that were not differentially expressed but displayed 
significant DTU. Subsequently, they confirmed three of them 
with qRT-PCR: TOM1L1 (ENSG00000141198), CMTM4 
(ENSG00000183723), and PEX11B (ENSG00000131779). 
Table 1 shows the fraction of the 248 DTU genes identified in 
this study that were also called by RATs, SUPPA2 and DRIM-
Seq, as well as each tool’s verdict on each of the three validated 
genes. The genes reported as DTU by RATs are listed in 
Extended data 3 & 433 respectively, based on the Ensembl v60 
and v87 human annotations.
None of the three tools recapitulated the reported 248 genes 
well, with the highest fraction of 26% achieved by DRIM-Seq 
possibly due to a tendency to over-predict (see next section). 
Of the three validated genes, only CMTM4 is reported by all 
methods, and only SUPPA2 reports all three genes. Although 
the rejection of TOM1L1 and PEX11B by DRIM-Seq was due 
to poor statistical significance, RATs reported that the changes 
found were both statistically significant and of sufficient effect 
size. Instead, RATs rejected the genes on the grounds of poor 
reproducibility (see Section: DTU Calling).
There have been extensive changes in the human transcrip-
tome annotation since Ensembl v60. We hypothesized that these 
changes could have a significant impact on the set of genes 
identified in Deng et al. (2013, 31). Table 2 shows that in addi-
tion to the new genome assembly, the human transcriptome 
complexity has increased significantly from Ensembl v60 to the 
more recent v87. Changing the version of the human annotation 
from Ensembl v60 to v87 removes 10,253 gene IDs and adds 
15,839 new ones. Re-quantifying the RNA-seq data with the 
updated annotation and re-calling DTU resulted in similarly 
poor overlap between the tools’ results and the original report 
(see Extended data 533). Of the three validated genes, TOM1L1 
was unanimously rejected by all methods, CMTM4 remained 
unanimously reported as DTU, and PEX11B was reported as 
DTU by RATs and SUPPA2, but not by DRIM-Seq.
The isoform abundances in Figure 4 reveal that all three genes 
showed plausible shifts in relative isoform abundance with the 
Ensembl v60 quantifications, but only PEX11B showed the 
same shift with Ensembl v87. Instead, TOM1L1 showed no 
significant changes in any of its 23 isoforms and the primary 
isoform in the Control samples changed from isoform 
2 (ENST00000445275) to isoform 1 (ENST00000348161). 
CMTM4 shows a similar abundance shift with v87 as it did 
with v60, but the isoforms implicated changed from isoforms 
1 (ENST00000330687) and 2 (ENST00000394106) to iso-
forms 1 and 5 (ENST00000581487). These changes of context 
raised questions about the qRT-PCR validation performed in the 
original analysis of the data31. Indeed, when the reported 
qRT-PCR primers were aligned to the Ensembl v87 sequence 
and annotation (see Extended data 633), only the primers for 
PEX11B yielded the same conclusion as with Ensembl v60. For 
TOM1L1, the primers intended for ENST00000445275 no longer 
matched that isoform, but matched two other isoforms instead 
(ENST00000570371 and ENST00000575882). Additionally, the 
primers intended to quantify the gene as a whole failed to match 
half of the gene’s new isoforms, and the two sets of captured 
Table 1. comparison of the results by Deng et al. (2013, 31) 
against the results of RATs, SUPPA2 and DRIM-Seq, using 
the same data and annotation (Ensembl v60). The first column 
shows the fraction of the 248 genes that was recaptured by each 
method. For methods reporting at the transcript level, results were 
aggregated to the respective genes. The last three columns show 
whether the verdicts for each of the validated genes (DTU Yes/No). 
DTU: Differential transcript usage.
Deng et al. 
(2013)31 TOM1L1 CMTM4 PEX11B
RATs (genes) 0.11 N Y N
RATs (tr. aggreg.) 0.11 N Y N
SUPPA2 (tr. aggreg.) 0.17 Y Y Y
DRIM-Seq 0.26 N Y N
Table 2. Expansion of the human annotation between Ensembl 
v60 and v87. In total, the later annotation contains 25% more 
transcript models. The three genes identified by Deng et al. 




Total TOM1L1 CMTM4 PEX11B
Ensembl v60 / GRCh37 157,480 2 2 2
Ensembl v87 / GRCh38 198,002 23 5 3
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Figure 4. Relative abundance of isoforms for the three validated genes from 31, as re-quantified with Salmon 0.7.114 using two versions 
of the Ensembl annotation. Isoform IDs on the x axis were replaced with simple numbers to minimize clutter, but the mapping of number to 
ID is maintained between the two annotations. The y axis represents the relative abundance of each isoform. In red are the quantifications 
from the three replicates of the Control condition, and in blue are those from the IPF condition. The full version of the plots by RATs, including 
the full isoform IDs, is available in Extended data 533.
isoforms did not overlap completely and were thus incompa-
rable in any meaningful way. As a consequence, the qRT-PCR 
intensities measured in the original study are actually impossi-
ble to interpret in the context of the updated annotation and the 
originally reported conclusion is likely wrong. For CMTM4 the 
primers reported matched multiple but not all isoforms, casting 
doubt on the interpretation of the qRT-PCR measurements for 
this gene as well. Only for PEX11B did the primers target the 
isoforms in a way that would give interpretable results and 
indeed lead to the same conclusion as originally reported31.
Comparison of DTU methods against Deng et al. (2013, 31)
Table 3 summarises the results obtained by RATs, SUPPA2 and 
DRIM-Seq for the Deng et al. (2013, 31) dataset using Ensembl 
v60 (same as the original study) and Ensembl v87 (current version 
at time of the present work). With either annotation, DRIM-Seq 
reported the most DTU genes – almost 1000 with v60 and 
almost 1700 with v87. The RATs gene-level method reported 
fewer genes by a factor of 1.5 and 2 respectively compared to 
DRIM-Seq with each annotation. SUPPA2 reported several 
hundred transcripts more than RATs, but at the gene level the 
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numbers were comparable. RATs and DRIM-Seq reported more 
genes and transcripts with v87 of the annotation than with v60, 
whereas SUPPA2 reported slightly fewer with v87. Despite 
overall similar volume of results between the two versions of 
the annotation, it is evident from Table 3 that the overlap of the 
results between annotations is poor for all methods. For RATs 
and SUPPA2, only 30–40% of the genes reported with Ensembl 
v60 were also reported with v87. For DRIM-Seq this overlap was 
55% of its Ensembl v60 results.
The overlap of results between different methods is similar 
to the overlap of results between annotations, as shown in 
Table 4. 97% of the genes reported by gene-level method in 
RATs are also identified as DTU by the transcript-level method. 
Among all the pairwise comparisons of RATs, SUPPA2 and 
DRIM-Seq, however, the highest level of agreement at both 
transcript and gene level is between SUPPA2 and RATs. SUPPA2 
identifies DTU in 53% of the transcripts that are called as 
DTU by the transcript-level method in RATs, however RATs 
calls DTU for only 35% of the transcripts identified as DTU 
by SUPPA2. DRIM-Seq consistently reports a higher number 
of DTU identifications than either RATs or SUPPA2, but still 
only manages at most 43% agreement with the other two 
tools.
RATs and SUPPA2 are more similar than implied by the level 
of agreement presented in Table 4. Figure 5 shows that the 
novel reproducibility testing feature in RATs, which discounts 
DTU identification from highly variable quantifications (see 
Section: DTU Calling), is responsible for rejecting 43% of 
the SUPPA2 DTU transcripts and 28% of the DRIM-Seq 
DTU genes that pass the significance and effect size filtering 
criteria. 53% of the DRIM-Seq results and, perplexingly, 18% of 
the SUPPA2 results are rejected due to the effect size filter (after 
passing the significance testing, but prior to the reproducibility 
filter), despite all the tools operating on the same input isoform 
quantifications.
Hardware requirements and run times
RATs’ runtime and memory consumption depend on the size of 
the annotation and the number of bootstraps iterations. Where 
multiple processing cores are available, RATs can be instructed 
Table 3. Summary of DTU features (genes or transcripts) detected by each 
method. DRIM-Seq reports DTU only at the gene level. SUPPA2 reports DTU only 
at the individual transcript level. RATs reports at both the transcript and the gene 
levels, using its respective test implementations. For SUPPA2 and the transcript-level 
approach in RATs, gene-level results can be inferred from the reported transcripts; 
these are included in the table, enclosed in parentheses. The last two columns 








SUPPA2 SUPPA2  
(tr. aggr.)
DRIM-Seq
RATs (genes) - 97% - 46% 19%
RATs (transc.) - - 35% - -
RATs (tr. aggr.) 78% - - 42% 17%
SUPPA2 - 53% - - -
SUPPA2 (tr. aggr.) 42% - 49% - 17%
DRIM-Seq 39% - 43% - 38%
Table 4. Overlap between the DTU results from RATs, SUPPA2 
and DRIM-Seq, for quantification of the Deng et al. (2013, 31) 
dataset based on Ensembl v87. The overlaps are shown as 
the proportion of the results from the methods on the columns 
captured by the methods on the rows.
Ensembl v60 Ensembl v87 Overlap  
(v60 & v87) 
genes transc genes transc genes transc
RATs (genes) 673 - 817 - 272 -
RATs (transc.) (553) 772 (652) 833 (213) 223
SUPPA2 (780) 1391 (753) 1252 (257) 374
DRIM-Seq 987 - 1680 - 541 -
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Figure 5. Causes of rejection by RATs of results reported by SUPPA2 or DRIM-Seq, expressed as proportion of the total DTU 
identifications reported by SUPPA2 (1252 transcripts) or DRIM-Seq (1680 genes). The colours represent the different criteria imposed by 
RATs. Since no abundance pre-filtering was enabled for any of the tools, there are no rejections caused by the transcript abundance and the 
effective number of expressed isoforms. DTU: Differential transcript usage.
Table 5. Runtime and maximum RAM usage for the Drosophila 
and human simulated datasets, running on a hyper-threaded 
quad-core 15” 2015 Macbook Pro with SSD and 16GB RAM. 
Measured via the peakRAM package36. For the bootstrapped runs, 
100 iterations were used for the quantification reproducibility and 9 
for the cross-replicate reproducibility, representing all the pairwise 
combinations of the 3 replicates per condition.



















100 + 9 1 02:11:13 4.25
8 00:47:47 4.15
to take advantage of them. The runtime and maximum memory 
usage for the two simulated datasets from our benchmarks, 
running on a high-specification laptop, are shown in Table 5.
Discussion
Reliable identification of differential isoform usage depends 
critically on i) the accuracy of the upstream isoform expression 
quantifications, and ii) on the accuracy of the annotation they 
use. RATs is the first differential isoform usage tool to include the 
reproducibility of the upstream isoform expression quantifica-
tions to refine its DTU identifications, directly addressing the 
accuracy of the upstream isoform expression quantifications. 
Leveraging the bootstrapped isoform expression quantifications 
from fast modern alignment-free isoform expression quantifi-
cation tools (such as Kallisto and Salmon) allows RATs to reject 
those cases of DTU that are based on highly uncertain isoform 
quantifications. Existing tools rely on the mean isoform abun-
dances, which can hide a large degree of variability, and are 
thus insensitive to this reproducibility criterion. We recommend 
running RATs, and the underlying alignment-free isoform 
expression quantification tools that generate the data it operates on, 
with at least 100 bootstrap iterations.
We evaluated RATs on both simulated data and on a high-quality 
experimental dataset from Deng et al. (2013, 31) and show that 
it outperforms both DRIM-Seq and SUPPA2. On the simulated 
data with stringent effect-size, reproducibility and statistical 
significance threshold, both the gene-level and transcript-level 
methods in RATs have a lower FDR than the other two tools, for 
a comparable sensitivity and comparable or superior Matthews 
correlation coefficient. This makes RATs particularly useful for 
data from organisms with large transcriptomes where the risk 
of false positives is higher. Relaxing these stringent thresholds 
increases the FDR for all the tools and for the lowest tested 
effect-size thresholds all the tools struggle to control their 
FDR adequately leaving little room for optimism regarding the 
identification of DTU with small effect sizes, particularly in 
low expression genes. The choice of alignment-free transcript 
quantification tool did not strongly affect the performance of the 
DTU tools within the examined parameter space, although in the 
simulated datasets Kallisto appears more prone to overestimat-
ing the expression of non-protein-coding genes that in the design 
of the simulation are not expressed (see Extended data 233). 
Comparing the DTU classifications of the three tools against the 
instances of DTU identified in the Deng et al. (2013, 31) data-
set, we found pairwise overlaps between the tools of at most 
53%. The low level of agreement between the three tools reflects 
their different methodological choices, such as the very differ-
ent definitions of effect size. Both SUPPA2 and RATs use the 
difference in relative isoform abundance as their measure of the 
DTU effect size, however RATs tests this difference directly 
whereas SUPPA2 extrapolates it from the differential inclusion 
of splice sites. This comparison also highlights the dependence 
of DTU identification methods on the accuracy of the under-
lying transcriptome annotation, (a limitation common to all 
biological tools that use an annotation as guide37). Running 
RATs, SUPPA2, and DRIM-Seq on the Deng et al. (2013, 31) 
datasets with two different versions of the ensembl H. sapiens 
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transcriptome annotation separated by six years produces 
dramatic differences in the DTU identification results. All 
three validated DTU genes from the original Deng et al. study 
contained additional isoforms in the newer annotation and only 
one of these genes displayed the same isoform abundance shifts 
using both annotations. With the newer annotation, the DTU 
of one validated gene was attributable to different isoforms 
depending on the annotation version, while another showed no 
significant DTU with the newer annotation. qRT-PCR has long 
considered the de facto standard for orthogonal confirmation 
of high-throughput transcriptomic results however it too is sub-
ject to the same limitation, illustrated by multiple matches of the 
specific primer sequences used for validation in the Deng et al. 
(2013, 31) study in the newer annotation. Annotation of the 
transcriptomes remains a work in progress even for model 
organisms and the extensive sequence overlap between isoforms 
together with the ongoing discovery of additional isoforms 
suggests that qRT-PCR may not be a suitable method for the 
validation of transcript abundance changes. For hybridization- 
based methods like qRT-PCR to serve as a reliable validation 
method for RNA quantification, the suitability of the primers 
should first be validated by sequencing the captured amplicons. 
Soneson et al. (2016,30) show that pre-filtering annotations can 
improve quantification performance and this approach may 
also be helpful in qRT-PCR primer design.
In the future, experiment-specific transcriptome annotations 
could be obtained by including a parallel set of full-length 
isoform RNA-seq data in the experimental design, such as via 
PacBio sequencing or Oxford Nanopore Direct RNA-seq. An 
advantage of this approach is that it would better define the 
transcriptome for the specific experiment38–41. This may be 
of importance for experiments focusing on specific tissues or 
developmental stages of an organism, where the active tran-
scriptome is likely to be only a subset of the global reference 
transcriptome of the organism.
Data availability
Underlying data
The Arabidopsis thaliana RNA-sequencing data used in this 
study is available from ArrayExpress under the study E-MTAB-
5446. The simulated Homo sapiens and Drosophila Mela-
nogaster datasets are available from ArrayExpress under the study 
E-MTAB-3766. The Deng et al. (2013, 31) data are available from 
the European Nucleotide Archive, or the Short Read Archive, 
under the study SRA048904.
Extended data
Extended data are available along with the source code from GitHub 
and archived with Zenodo




The RATs R package is open source and available through Github
Source code: https://github.com/bartongroup/RATs.
Archived source code: http://doi.org/10.5281/zenodo.255656433
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